 |
 |
|
|
|  PubMed
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 October 2001 | Volume 135 Issue 8 Part 1 | Pages 566-576
Background: Microsatellite instability is a hallmark of mismatch repair deficiency in hereditary nonpolyposis colorectal cancer and results from mutations in the mismatch repair genes MLH1 or MSH2 or from gene inactivation associated with DNA methylation. The Bethesda guidelines were established to identify patients with colorectal cancer who should be tested for microsatellite instability.
Objective: To assess the Bethesda guidelines for detection of microsatellite instability and to determine the role of MLH1 promoter methylation in colorectal cancer.
Design: Prospective cohort study.
Setting: Tertiary care referral center in Frankfurt, Germany.
Patients: 125 consecutive patients with colorectal cancer.
Measurements: Patients were assessed according to the Bethesda guidelines, and tumor specimens were analyzed for microsatellite instability. Patients with microsatellite instability were tested for MLH1 promoter methylation and MLH1 and MSH2 germline mutations.
Results: Microsatellite instability was detected in 17 of 58 patients who fulfilled and 5 of 67 patients who did not fulfill criteria of the Bethesda guidelines. In 11 of 17 patients with microsatellite instability who fulfilled Bethesda guidelines, an MLH1 (n = 3), MSH2 (n = 7), or combined MLH1 and MSH2 (n = 1) mutation was found. Among the patients with microsatellite instability who did not fulfill Bethesda guidelines, no mutations were observed; MLH1 promoter methylation was observed in 6 of 11 patients with an MLH1 or MSH2 mutation and 5 of 11 patients without an MLH1 or MSH2 mutation.
Conclusions: The Bethesda guidelines are useful for selecting patients for microsatellite instability testing. MLH1 and MSH2 testing should be recommended in all patients with colorectal cancer and microsatellite instability who fulfill at least one Bethesda criterion. MLH1 promoter methylation may accompany rather than initiate carcinogenesis in patients with colorectal cancer who have mismatch repair gene defects.
Author and Article Information
From Johann Wolfgang Goethe-University, Frankfurt, Germany.
Acknowledgments: The authors thank Ralf Lieberz for technical support and Hanns Ackermann and Eva Herrmann for statistical advice.
Grant Support: By research grant F 15/99 from the University of Frankfurt.
Requests for Single Reprints: Jochen Raedle, MD, Second Department of Internal Medicine, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany; e-mail, Raedle{at}em.uni-frankfurt.de.
Current Author Addresses: Drs. Raedle, Trojan, Brieger, and Zeuzem, Ms. Weber, and Mr. Plotz: Second Department of Internal Medicine, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
Dr. Schäfer: Institute of Human Genetics, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
Drs. Staib-Sebler and Lorenz: Department of General and Vascular Surgery, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
Dr. Kriener: Department of Pathology, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
Author Contributions: Conception and design: J. Raedle, J. Trojan, A. Brieger, S. Zeuzem.
Analysis and interpretation of the data: J. Raedle, J. Trojan, A. Brieger, D. Schäfer.
Drafting of the article: J. Raedle, J. Trojan, D. Schäfer.
Critical revision of the article for important intellectual content: D. Schäfer, M. Lorenz, S. Zeuzem.
Final approval of the article: J. Raedle, J. Trojan, A. Brieger, N. Weber, D. Schäfer, G. Plotz, E. Staib-Sebler, S. Kriener, M. Lorenz, S. Zeuzem.
Provision of study materials or patients: J. Raedle, D. Schäfer, E. Staib-Sebler, S. Kriener, M. Lorenz, S. Zeuzem.
Statistical expertise: J. Raedle.
Obtaining of funding: J. Raedle.
Administrative, technical, or logistic support: N. Weber, S. Kriener, S. Zeuzem.
Collection and assembly of data: J. Raedle, J. Trojan, A. Brieger, N. Weber, G. Plotz, E. Staib-Sebler. ARTICLE
Bethesda Guidelines: Relation to Microsatellite Instability and MLH1 Promoter Methylation in Patients with Colorectal Cancer
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  M. Bettstetter, S. Dechant, P. Ruemmele, M. Grabowski, G. Keller, E. Holinski-Feder, A. Hartmann, F. Hofstaedter, and W. Dietmaier Distinction of Hereditary Nonpolyposis Colorectal Cancer and Sporadic Microsatellite-Unstable Colorectal Cancer through Quantification of MLH1 Methylation by Real-time PCR Clin. Cancer Res., June 1, 2007; 13(11): 3221 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Plotz, C. Welsch, L. Giron-Monzon, P. Friedhoff, M. Albrecht, A. Piiper, R. M. Biondi, T. Lengauer, S. Zeuzem, and J. Raedle Mutations in the MutS{alpha} interaction interface of MLH1 can abolish DNA mismatch repair Nucleic Acids Res., December 2, 2006; 34(22): 6574 - 6586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Plotz, J. Raedle, A. Brieger, J. Trojan, and S. Zeuzem N-terminus of hMLH1 confers interaction of hMutL{alpha} and hMutL{beta} with hMutS{alpha} Nucleic Acids Res., June 15, 2003; 31(12): 3217 - 3226. [Abstract] [Full Text] [PDF]
|
|
